• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study.

作者信息

Hermann Emilia A, Lee Benjamin, Balte Pallavi P, Xanthakis Vanessa, Kirkpatrick Beth D, Cushman Mary, Oelsner Elizabeth

机构信息

Division of General Medicine, Department of Medicine, Columbia University, New York, New York.

Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington.

出版信息

JAMA Netw Open. 2022 Oct 3;5(10):e2237908. doi: 10.1001/jamanetworkopen.2022.37908.

DOI:10.1001/jamanetworkopen.2022.37908
PMID:36269359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9587476/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f2/9587476/8b9f7e743eb9/jamanetwopen-e2237908-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f2/9587476/8b9f7e743eb9/jamanetwopen-e2237908-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f2/9587476/8b9f7e743eb9/jamanetwopen-e2237908-g001.jpg

相似文献

1
Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study.弗雷明汉心脏研究中新冠疫苗接种后症状与抗SARS-CoV-2抗体反应的关联
JAMA Netw Open. 2022 Oct 3;5(10):e2237908. doi: 10.1001/jamanetworkopen.2022.37908.
2
Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.健康受试者对 mRNA COVID-19 疫苗的抗体反应差异。
Microbiol Spectr. 2021 Sep 3;9(1):e0034121. doi: 10.1128/Spectrum.00341-21. Epub 2021 Aug 4.
3
Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19.两剂灭活新冠疫苗接种对感染和未感染新冠病毒的医护人员抗体反应的疗效。
J Med Virol. 2022 Jun;94(6):2431-2437. doi: 10.1002/jmv.27649. Epub 2022 Feb 14.
4
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study.描述 COVID-19 感染和单剂疫苗接种后康复个体的纵向抗体反应：一项前瞻性队列研究。
Viruses. 2022 Oct 31;14(11):2416. doi: 10.3390/v14112416.
5
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease.COVID-19 疫苗接种对炎症性肠病患者的长期有效性和持久性。
Clin Gastroenterol Hepatol. 2024 Jul;22(7):1475-1486.e4. doi: 10.1016/j.cgh.2024.02.001. Epub 2024 Feb 17.
6
The Healthcare Study Examines the Humoral Anti-S1 Antibody Response Following mRNA Vaccination, Comparing Individuals with and without Prior SARS-CoV-2 Infection.该医疗保健研究考察了 mRNA 疫苗接种后体液抗 S1 抗体的反应，比较了有和无既往 SARS-CoV-2 感染的个体。
Arch Immunol Ther Exp (Warsz). 2024 Aug 15;72(1). doi: 10.2478/aite-2024-0016. eCollection 2024 Jan 1.
7
Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.炎症性肠病患者接种 SARS-CoV-2 疫苗后抗体生成受损：一项泛希腊注册研究的结果。
Inflamm Bowel Dis. 2023 Feb 1;29(2):228-237. doi: 10.1093/ibd/izac068.
8
SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report.接种疫苗后儿科心脏移植患者体内的 SARS-CoV-2 刺突抗体：首报。
J Heart Lung Transplant. 2022 Feb;41(2):133-136. doi: 10.1016/j.healun.2021.11.001. Epub 2021 Nov 14.
9
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.医护人员接种 COVID-19 疫苗 6 个月后抗体反应的持久性和 SARS-CoV-2 感染的频率。
Emerg Infect Dis. 2022 Apr;28(4):828-832. doi: 10.3201/eid2804.212037. Epub 2022 Feb 24.
10
Use of Self-Collected Dried Blood Spots and a Multiplex Microsphere Immunoassay to Measure IgG Antibody Response to COVID-19 Vaccines.使用自采干血斑和多重微球免疫分析测定对 COVID-19 疫苗的 IgG 抗体反应。
Microbiol Spectr. 2023 Feb 14;11(1):e0133622. doi: 10.1128/spectrum.01336-22. Epub 2023 Jan 9.

引用本文的文献

1
Longitudinal study on immunologic, lipoproteomic, and inflammatory responses indicates the safety of sequential COVID-19 vaccination.关于免疫、脂蛋白组学和炎症反应的纵向研究表明了序贯新冠病毒疫苗接种的安全性。
J Mol Med (Berl). 2025 Apr;103(4):421-433. doi: 10.1007/s00109-025-02527-y. Epub 2025 Mar 12.
2
Association between adverse events after COVID-19 vaccination and anti-SARS-CoV-2 antibody concentrations, the Netherlands, May 2021 to November 2022: a population-based prospective cohort study.2021 年 5 月至 2022 年 11 月期间，荷兰一项基于人群的前瞻性队列研究显示，接种新冠疫苗后出现不良反应与抗 SARS-CoV-2 抗体浓度之间存在关联。
Euro Surveill. 2024 Jun;29(25). doi: 10.2807/1560-7917.ES.2024.29.25.2300585.
3

本文引用的文献

1
Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design.协作队列的队列 COVID-19 研究 (C4R) 研究:研究设计。
Am J Epidemiol. 2022 Jun 27;191(7):1153-1173. doi: 10.1093/aje/kwac032.
2
Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2.BNT162b2疫苗接种后反应原性与免疫原性之间的关联
Vaccines (Basel). 2021 Sep 27;9(10):1089. doi: 10.3390/vaccines9101089.
3
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty).
COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A Prospective Cohort Study.
COVID-19 疫苗的副作用和长期中和抗体反应：一项前瞻性队列研究。
Ann Intern Med. 2024 Jul;177(7):892-900. doi: 10.7326/M23-2956. Epub 2024 Jun 11.
4
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.对前新冠病毒疫苗候选物CVnCoV的先天反应及其与反应原性和适应性免疫原性的关系。
Vaccines (Basel). 2024 Apr 6;12(4):388. doi: 10.3390/vaccines12040388.
5
No Evidence That Analgesic Use after COVID-19 Vaccination Negatively Impacts Antibody Responses.没有证据表明 COVID-19 疫苗接种后使用镇痛药会对抗体反应产生负面影响。
Immunohorizons. 2023 Dec 1;7(12):834-841. doi: 10.4049/immunohorizons.2300090.
6
The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review.Novavax 异源冠状病毒病 2019 加强针比信使 RNA 疫苗的反应原性更低：一项有针对性的综述。
J Infect Dis. 2024 Aug 16;230(2):e496-e502. doi: 10.1093/infdis/jiad519.
7
Side Effects of COVID-19 Vaccines in Pregnant and Lactating Mexican Women and Breastfed Infants: A Survey-Based Study.墨西哥孕妇、哺乳期妇女及母乳喂养婴儿接种新冠疫苗的副作用：一项基于调查的研究
Vaccines (Basel). 2023 Jul 25;11(8):1280. doi: 10.3390/vaccines11081280.
8
From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics.从 bench 到 bedside：脂质纳米颗粒载体反应原性对推进核酸治疗的影响 。 （注：bench 和 bedside 在这里可能是特定语境下的术语，比如 bench 可能表示实验室研究阶段，bedside 表示临床应用阶段，可根据具体背景进一步准确理解，这里按字面翻译）
Pharmaceuticals (Basel). 2023 Jul 31;16(8):1088. doi: 10.3390/ph16081088.
9
Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination.双侧和单侧接种 COVID-19 疫苗后 SARS-CoV-2 特异性体液和细胞免疫反应的差异。
EBioMedicine. 2023 Sep;95:104743. doi: 10.1016/j.ebiom.2023.104743. Epub 2023 Aug 11.
10
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases.免疫介导的炎症性疾病患者对 COVID-19 的易感性和疫苗接种的免疫反应。
J Infect Dis. 2023 Aug 4;228(Suppl 1):S13-S23. doi: 10.1093/infdis/jiad148.
接种BNT162b2 mRNA（Comirnaty）新冠疫苗后，反应原性与体液免疫原性仅存在微弱关联。
Vaccines (Basel). 2021 Sep 24;9(10):1063. doi: 10.3390/vaccines9101063.
4
Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers.疫苗类型和既往 SARS-CoV-2 感染与医护人员接种疫苗后症状和抗体测量的关联。
JAMA Intern Med. 2021 Dec 1;181(12):1660-1662. doi: 10.1001/jamainternmed.2021.4580.
5
High-Throughput Multiplex SARS-CoV-2 IgG Microsphere Immunoassay for Dried Blood Spots: A Public Health Strategy for Enhanced Serosurvey Capacity.高通量多重 SARS-CoV-2 IgG 微球免疫分析检测干血斑：增强血清学调查能力的公共卫生策略。
Microbiol Spectr. 2021 Sep 3;9(1):e0013421. doi: 10.1128/Spectrum.00134-21. Epub 2021 Jul 28.
6
Can reactogenicity predict immunogenicity after COVID-19 vaccination?接种 COVID-19 疫苗后，反应原性能否预测免疫原性？
Korean J Intern Med. 2021 Nov;36(6):1486-1491. doi: 10.3904/kjim.2021.210. Epub 2021 May 28.